AI Verdict
RGEN has stronger fundamentals based on our AI analysis.
RGEN vs RGBPP Fundamental Comparison
| Metric | RGEN | RGBPP |
|---|---|---|
| Revenue | $738.3M | $59,065.0 |
| Net Income | $48.9M | $-967,853.0 |
| Net Margin | 6.6% | -1,638.6% |
| ROE | 2.3% | N/A |
| ROA | 1.7% | -408.2% |
| Current Ratio | 8.37x | 0.03x |
| Debt/Equity | 0.26x | N/A |
| EPS | $0.86 | $-0.01 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RGEN vs RGBPP: Frequently Asked Questions
Is RGEN or RGBPP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RGEN has stronger fundamentals. RGEN is rated HOLD (62% confidence) while RGBPP is rated STRONG SELL (95% confidence). This is not investment advice.
How does RGEN compare to RGBPP fundamentally?
REPLIGEN CORP has ROE of 2.3% vs Regen BioPharma Inc's N/A. Net margins are 6.6% vs -1,638.6% respectively.
Which stock pays higher dividends, RGEN or RGBPP?
RGEN has a dividend yield of N/A or no dividend while RGBPP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RGEN or RGBPP for long term?
For long-term investing, consider that RGEN has HOLD rating with 62% confidence, while RGBPP has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RGEN vs RGBPP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RGEN vs RGBPP, the AI consensus favors RGEN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.